Immatics Builds on Genedata Biologics for Cell Therapy Innovation
公司规模
200-1,000
地区
- Europe
国家
- Germany
产品
- Genedata Biologics
- XPRESIDENT
- XCEPTOR
技术栈
- Data Management Platforms
- Data Visualization
- Database Management & Storage
实施规模
- Enterprise-wide Deployment
影响指标
- Cost Savings
- Innovation Output
- Productivity Improvements
技术
- 应用基础设施与中间件 - 数据可视化
- 应用基础设施与中间件 - 数据库管理和存储
- 平台即服务 (PaaS) - 数据管理平台
适用行业
- 医疗保健和医院
- 生命科学
适用功能
- 产品研发
- 质量保证
用例
- Condition Monitoring
- 预测性维护
- 过程控制与优化
服务
- 数据科学服务
- 系统集成
关于客户
Immatics is a globally operating clinical-stage biopharmaceutical company that is developing novel T cell receptor (TCR) -based immunotherapies. The company focuses on the treatment of cancer patients with solid tumors. To develop T cell receptor-based immunotherapies, Immatics employs two innovative proprietary technologies. Immatics’ XPRESIDENT® technology is one of the largest mass spectrometry platforms in the world, encompassing numerous tumor sample spectra. This allows Immatics to identify the peptides unique to tumor tissue, representing potential novel cancer targets. Immatics’ XCEPTOR® technology is used to identify T cell receptors that bind the tumor-specific targets, isolate their binding regions, and further optimize them for even greater specificity and improved affinity. Protein engineering is then applied to design and produce TCRs with desired binding characteristics for use in two therapeutic approaches: autologous and allogeneic adoptive cell therapies and TCR-based bispecific molecules. The company’s proprietary pipeline currently includes seven product candidates in pre-clinical and clinical stages. Ten additional programs are developed with leading biopharmaceutical companies such as Bristol Myers Squibb, GlaxoSmithKline, Amgen, and Genmab.
挑战
Immatics is a clinical-stage biopharmaceutical company that focuses on the development of novel therapies to treat cancer patients with solid tumors. The company employs two innovative proprietary technologies, XPRESIDENT® and XCEPTOR®, to develop T cell receptor-based immunotherapies. The TCR-related R&D workflow at Immatics is very sophisticated, involving hundreds of individual steps and iterations to generate new molecules and cell lines, engineer and optimize the therapeutic modalities, and constantly test and monitor them to see if they are fit-for-purpose. Each step generates critically important data that needs to be captured, processed, analyzed, and made available to various R&D teams. The complex data stream includes all molecule, sequence, and sample details, assay, and analytics values, as well as decisions such as the CDR combinations to be used to engineer distinctive TCR bispecific molecules. This data must be integrated, stored, related, and interpreted in real time to support the day-to-day activities of the various Immatics’ R&D teams.
解决方案
Immatics performed a comprehensive market assessment, based on their specific requirements, before choosing Genedata Biologics®. While the preference was for a commercial off-the-shelf (COTS) product to provide a maximum of built-in functionalities, facilitate deployment, and ensure future maintenance, a custom development project was also considered. During the deployment project, Genedata worked closely with Immatics to optimally set up the platform and configure Immatics-specific CGT workflows. With extensive domain knowledge and experience from working with both small and large cell and gene therapy companies, Genedata knows how to accelerate, simplify, and optimize specialized CGT processes directly with each customer. Genedata Biologics is now used productively for all proprietary and partnered R&D programs at Immatics, including bispecifics and adoptive cell therapies. As an integrated workflow platform, it enables efficient screening, engineering, production, and testing of TCRs and TCR-based molecules, as well as lentivirus production and cell line development. The system comprehensively tracks properties of each therapeutic candidate, including specificity, efficacy, safety, stability, manufacturability, and developability. It also provides the necessary scalability to support Immatics’ quickly growing R&D organization.
运营影响
数量效益
Case Study missing?
Start adding your own!
Register with your work email and create a new case study profile for your business.
相关案例.
Case Study
Hospital Inventory Management
The hospital supply chain team is responsible for ensuring that the right medical supplies are readily available to clinicians when and where needed, and to do so in the most efficient manner possible. However, many of the systems and processes in use at the cancer center for supply chain management were not best suited to support these goals. Barcoding technology, a commonly used method for inventory management of medical supplies, is labor intensive, time consuming, does not provide real-time visibility into inventory levels and can be prone to error. Consequently, the lack of accurate and real-time visibility into inventory levels across multiple supply rooms in multiple hospital facilities creates additional inefficiency in the system causing over-ordering, hoarding, and wasted supplies. Other sources of waste and cost were also identified as candidates for improvement. Existing systems and processes did not provide adequate security for high-cost inventory within the hospital, which was another driver of cost. A lack of visibility into expiration dates for supplies resulted in supplies being wasted due to past expiry dates. Storage of supplies was also a key consideration given the location of the cancer center’s facilities in a dense urban setting, where space is always at a premium. In order to address the challenges outlined above, the hospital sought a solution that would provide real-time inventory information with high levels of accuracy, reduce the level of manual effort required and enable data driven decision making to ensure that the right supplies were readily available to clinicians in the right location at the right time.
Case Study
Gas Pipeline Monitoring System for Hospitals
This system integrator focuses on providing centralized gas pipeline monitoring systems for hospitals. The service they provide makes it possible for hospitals to reduce both maintenance and labor costs. Since hospitals may not have an existing network suitable for this type of system, GPRS communication provides an easy and ready-to-use solution for remote, distributed monitoring systems System Requirements - GPRS communication - Seamless connection with SCADA software - Simple, front-end control capability - Expandable I/O channels - Combine AI, DI, and DO channels
Case Study
Driving Digital Transformations for Vitro Diagnostic Medical Devices
Diagnostic devices play a vital role in helping to improve healthcare delivery. In fact, an estimated 60 percent of the world’s medical decisions are made with support from in vitrodiagnostics (IVD) solutions, such as those provided by Roche Diagnostics, an industry leader. As the demand for medical diagnostic services grows rapidly in hospitals and clinics across China, so does the market for IVD solutions. In addition, the typically high cost of these diagnostic devices means that comprehensive post-sales services are needed. Wanteed to improve three portions of thr IVD:1. Remotely monitor and manage IVD devices as fixed assets.2. Optimizing device availability with predictive maintenance.3. Recommending the best IVD solution for a customer’s needs.
Case Study
HaemoCloud Global Blood Management System
1) Deliver a connected digital product system to protect and increase the differentiated value of Haemonetics blood and plasma solutions. 2) Improve patient outcomes by increasing the efficiency of blood supply flows. 3) Navigate and satisfy a complex web of global regulatory compliance requirements. 4) Reduce costly and labor-intensive maintenance procedures.
Case Study
Harnessing real-time data to give a holistic picture of patient health
Every day, vast quantities of data are collected about patients as they pass through health service organizations—from operational data such as treatment history and medications to physiological data captured by medical devices. The insights hidden within this treasure trove of data can be used to support more personalized treatments, more accurate diagnosis and more advanced preparative care. But since the information is generated faster than most organizations can consume it, unlocking the power of this big data can be a struggle. This type of predictive approach not only improves patient care—it also helps to reduce costs, because in the healthcare industry, prevention is almost always more cost-effective than treatment. However, collecting, analyzing and presenting these data-streams in a way that clinicians can easily understand can pose a significant technical challenge.